MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALMKT - FR0010609263 - Common Stock
ALMKT.PA Key Statistics, Chart & Performance
The current stock price of ALMKT.PA is 0.091 EUR. In the past month the price increased by 28.22%. In the past year, price decreased by -48.04%.
ALMKT.PA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ALMKT.PA. When comparing the yearly performance of all stocks, ALMKT.PA is a bad performer in the overall market: 93.94% of all stocks are doing better.
ALMKT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA. ALMKT.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
ALMKT.PA Financial Highlights
Over the last trailing twelve months ALMKT.PA reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS decreased by -114.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALMKT.PA Forecast & Estimates
9 analysts have analysed ALMKT.PA and the average price target is 0.51 EUR. This implies a price increase of 460.44% is expected in the next year compared to the current price of 0.091.
ALMKT.PA Ownership
ALMKT.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.35 | 107.89B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 19.62 | 52.88B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.69 | 50.40B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 17.36 | 24.74B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.34 | 24.72B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.55 | 23.58B | ||
| BIM.PA | BIOMERIEUX | 27.05 | 12.36B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 142.23 | 4.28B | ||
| DIA.MI | DIASORIN SPA | 22.82 | 4.23B | ||
| 1AFX.MI | CARL ZEISS MEDITEC AG - BR | 23.24 | 3.55B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 23.3 | 3.36B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 14.25 | 1.72B |
Related stock screener links
About ALMKT.PA
Company Profile
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France and currently employs 61 full-time employees. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
Company Info
MAUNA KEA TECHNOLOGIES
9, rue d'Enghien
Paris ILE-DE-FRANCE FR
Employees: 65
Phone: 33148240345
MAUNA KEA TECHNOLOGIES / ALMKT.PA FAQ
What does MAUNA KEA TECHNOLOGIES do?
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France and currently employs 61 full-time employees. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
What is the stock price of MAUNA KEA TECHNOLOGIES today?
The current stock price of ALMKT.PA is 0.091 EUR. The price increased by 9.64% in the last trading session.
Does MAUNA KEA TECHNOLOGIES pay dividends?
ALMKT.PA does not pay a dividend.
How is the ChartMill rating for MAUNA KEA TECHNOLOGIES?
ALMKT.PA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What do analysts say about MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
9 analysts have analysed ALMKT.PA and the average price target is 0.51 EUR. This implies a price increase of 460.44% is expected in the next year compared to the current price of 0.091.
Can you provide the sector and industry classification for MAUNA KEA TECHNOLOGIES?
MAUNA KEA TECHNOLOGIES (ALMKT.PA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.